Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population

Lauren C. Shapiro; Jennat Mustafa; Amanda Lombardo; Fariha Khatun; Felisha Joseph; Kailyn Gillick; Anjali Naik; Richard Elkind; Michelly Abreu; Karen Fehn; Alyssa de Castro; Kith Pradhan; Donika Binakaj; Randin Nelson; Monika Paroder; Joan Uehlinger; Kira Gritsman; R. Alejandro Sica; Noah Kornblum; Aditi Shastri; Ioannis Mantzaris; Lizamarie Bachier-Rodriguez; Amit Verma; Ira Braunschweig; Mendel Goldfinger

doi:10.1038/s41409-021-01280-3

Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population

Lauren C. Shapiro, Jennat Mustafa, Amanda Lombardo, Fariha Khatun, Felisha Joseph, Kailyn Gillick, Anjali Naik, Richard Elkind, Michelly Abreu, Karen Fehn, Alyssa de Castro, Kith Pradhan, Donika Binakaj, Randin Nelson, Monika Paroder, Joan Uehlinger, Kira Gritsman, R. Alejandro Sica, Noah Kornblum, Aditi ShastriIoannis Mantzaris, Lizamarie Bachier-Rodriguez, Amit Verma, Ira Braunschweig, Mendel Goldfinger

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1761-1763
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	56
Issue number	7
DOIs	https://doi.org/10.1038/s41409-021-01280-3
State	Published - Jul 2021

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/s41409-021-01280-3

Cite this

Shapiro, L. C., Mustafa, J., Lombardo, A., Khatun, F., Joseph, F., Gillick, K., Naik, A., Elkind, R., Abreu, M., Fehn, K., de Castro, A., Pradhan, K., Binakaj, D., Nelson, R., Paroder, M., Uehlinger, J., Gritsman, K., Alejandro Sica, R., Kornblum, N., ... Goldfinger, M. (2021). Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population. Bone Marrow Transplantation, 56(7), 1761-1763. https://doi.org/10.1038/s41409-021-01280-3

Shapiro, LC, Mustafa, J, Lombardo, A, Khatun, F, Joseph, F, Gillick, K, Naik, A, Elkind, R, Abreu, M, Fehn, K, de Castro, A, Pradhan, K, Binakaj, D, Nelson, R , Paroder, M, Uehlinger, J, Gritsman, K , Alejandro Sica, R , Kornblum, N , Shastri, A , Mantzaris, I, Bachier-Rodriguez, L, Verma, A, Braunschweig, I & Goldfinger, M 2021, 'Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population', Bone Marrow Transplantation, vol. 56, no. 7, pp. 1761-1763. https://doi.org/10.1038/s41409-021-01280-3

@article{c60d37b3a90641daab2c699e5a9c2b69,

title = "Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population",

author = "Shapiro, {Lauren C.} and Jennat Mustafa and Amanda Lombardo and Fariha Khatun and Felisha Joseph and Kailyn Gillick and Anjali Naik and Richard Elkind and Michelly Abreu and Karen Fehn and {de Castro}, Alyssa and Kith Pradhan and Donika Binakaj and Randin Nelson and Monika Paroder and Joan Uehlinger and Kira Gritsman and {Alejandro Sica}, R. and Noah Kornblum and Aditi Shastri and Ioannis Mantzaris and Lizamarie Bachier-Rodriguez and Amit Verma and Ira Braunschweig and Mendel Goldfinger",

note = "Funding Information: Conflict of interest Dr RAS serves as a consultant with Morphosys and Miragen and is on the faculty at Physicians{\textquoteright} Education Research. Dr AS has received research funding from Kymera Therapeutics and serves as a consultant with Guidepoint, GLG. Dr AV has received research funding from BMS, Jannsen, and has equity stake in Stelexis Inc. The remaining authors declare no competing interests.",

year = "2021",

month = jul,

doi = "10.1038/s41409-021-01280-3",

language = "English (US)",

volume = "56",

pages = "1761--1763",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population

AU - Shapiro, Lauren C.

AU - Mustafa, Jennat

AU - Lombardo, Amanda

AU - Khatun, Fariha

AU - Joseph, Felisha

AU - Gillick, Kailyn

AU - Naik, Anjali

AU - Elkind, Richard

AU - Abreu, Michelly

AU - Fehn, Karen

AU - de Castro, Alyssa

AU - Pradhan, Kith

AU - Binakaj, Donika

AU - Nelson, Randin

AU - Paroder, Monika

AU - Uehlinger, Joan

AU - Gritsman, Kira

AU - Alejandro Sica, R.

AU - Kornblum, Noah

AU - Shastri, Aditi

AU - Mantzaris, Ioannis

AU - Bachier-Rodriguez, Lizamarie

AU - Verma, Amit

AU - Braunschweig, Ira

AU - Goldfinger, Mendel

N1 - Funding Information: Conflict of interest Dr RAS serves as a consultant with Morphosys and Miragen and is on the faculty at Physicians’ Education Research. Dr AS has received research funding from Kymera Therapeutics and serves as a consultant with Guidepoint, GLG. Dr AV has received research funding from BMS, Jannsen, and has equity stake in Stelexis Inc. The remaining authors declare no competing interests.

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85104144772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104144772&partnerID=8YFLogxK

U2 - 10.1038/s41409-021-01280-3

DO - 10.1038/s41409-021-01280-3

M3 - Letter

C2 - 33846558

AN - SCOPUS:85104144772

VL - 56

SP - 1761

EP - 1763

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 7

ER -

Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this